- FoxD2-AS1 is a prognostic factor in glioma and promotes temozolomide resistance in a Oâ¶-methylguanine-DNA methyltransferase-dependent manner
-
Shangguan , Lv X, Tian N
- KMID: 2461040
- Korean J Physiol Pharmacol.
- 2019 Nov;23(6):475-482.
- doi: 10.4196/kjpp.2019.23.6.475
Glioma is the most common brain tumor with a dismal prognosis. While temozolomide (TMZ) based chemotherapy significantly improves survival in glioma patients, resistance against this compound commonly leads to glioma... -
- CITED
-
- Close
- SHARE
-
- Close
